Status:
UNKNOWN
A Multi-center Study of the Effect of Orthokeratology on Myopia Progression
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions:
Myopia
Eligibility:
All Genders
8-15 years
Brief Summary
This is a prospective study to validate an algorithm for predicting the effect of orthokeratology on myopia progression in children from 8 hospitals in China.
Detailed Description
Orthokeratology (ortho-K) is thought to be an effective way to control the progression of Myopia in children, but its effectiveness may vary among different individuals. The investigators therefore co...
Eligibility Criteria
Inclusion
- -6.0D≤SER≤-0.5D
- Astigmatism≤2.0D
Exclusion
- Contraindications of wearing Ortho-K.
- Diagnosis of strabismus, amblyopia and other refractive development of the eye or systemic diseases.
- Currently involved in other clinical studies.
Key Trial Info
Start Date :
February 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04284111
Start Date
February 26 2020
End Date
August 1 2021
Last Update
February 28 2020
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hefei Bright Eye Hospital
Hefei, Anhui, China
2
Zhongshan Ophthalmic Center (Haizhu Branch), Sun Yat-sen University
Guangzhou, Guangdong, China
3
Wuhan Bright Eye hospital
Wuhan, Hubei, China
4
Nanchang Bright Eye Hospital
Nanchang, Jiangxi, China